AI assistant
LB PHARMACEUTICALS INC — Director's Dealing 2025
Sep 30, 2025
33183_dirs_2025-09-29_a90f9420-0228-4cf4-867e-09f141795e18.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LB PHARMACEUTICALS INC (LBRX)
CIK: 0001691082
Period of Report: 2025-09-10
Reporting Person: PANOFF MARC L (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10242 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $64.15 | 2028-11-13 | Common Stock (3944) | Direct | |
| Employee Stock Option (Right to Buy) | $69.72 | 2029-12-22 | Common Stock (896) | Direct | |
| Employee Stock Option (Right to Buy) | $69.72 | 2030-08-30 | Common Stock (1255) | Direct | |
| Employee Stock Option (Right to Buy) | $41.84 | 2033-08-24 | Common Stock (14343) | Direct | |
| Employee Stock Option (Right to Buy) | $41.84 | 2034-06-26 | Common Stock (7171) | Direct |
Footnotes
F1: Immediately exercisable.
F2: One fourth (1/4) of the shares subject to the option award vested on August 25, 2024 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F3: One fourth (1/4) of the shares subject to the option award vested on June 28, 2025 and the remaining shares subject to the option vested or shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.